DGAP-Adhoc: Carl Zeiss Meditec AG achieves significant growth in revenue and profit in fiscal year 2018/19
DGAP-Ad-hoc: Carl Zeiss Meditec AG / Key word(s): Annual Results
Contact for investors and press [1] Currency-adjusted sales growth is determined by weighing sales in the comparative period with current instead of actual historical exchange rates.
02-Oct-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Carl Zeiss Meditec AG |
Göschwitzer Str. 51-52 | |
07745 Jena | |
Germany | |
Phone: | +49 (0)3641 220-0 |
Fax: | +49 (0)3641 220-112 |
E-mail: | [email protected] |
Internet: | www.zeiss.de/meditec-ag/ir |
ISIN: | DE0005313704 |
WKN: | 531370 |
Indices: | MDAX, TecDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 884075 |
End of Announcement | DGAP News Service |
|
884075 02-Oct-2019 CET/CEST
Carl Zeiss Meditec AG Stock
With 2 Buy predictions and 1 Sell predictions the community is currently undecided on Carl Zeiss Meditec AG.
With a target price of 122 € there is potential for a 106.26% increase which would mean more than doubling the current price of 59.15 € for Carl Zeiss Meditec AG.